PORCELLI, LETIZIA
 Distribuzione geografica
Continente #
NA - Nord America 2.073
AS - Asia 801
EU - Europa 676
SA - Sud America 247
AF - Africa 53
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.856
Nazione #
US - Stati Uniti d'America 2.026
SG - Singapore 315
BR - Brasile 202
IT - Italia 199
CN - Cina 157
RU - Federazione Russa 120
SE - Svezia 110
HK - Hong Kong 94
VN - Vietnam 73
DE - Germania 61
GB - Regno Unito 46
FR - Francia 45
CA - Canada 30
FI - Finlandia 28
IN - India 26
CI - Costa d'Avorio 24
BE - Belgio 21
ID - Indonesia 17
BD - Bangladesh 16
AR - Argentina 15
TR - Turchia 15
IQ - Iraq 14
JP - Giappone 13
AT - Austria 10
ZA - Sudafrica 9
CO - Colombia 8
MX - Messico 8
UZ - Uzbekistan 8
VE - Venezuela 8
NL - Olanda 7
LT - Lituania 6
PK - Pakistan 6
PL - Polonia 6
TN - Tunisia 6
EC - Ecuador 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
KR - Corea 4
MA - Marocco 4
NP - Nepal 4
PY - Paraguay 4
AU - Australia 3
AZ - Azerbaigian 3
BO - Bolivia 3
ES - Italia 3
JO - Giordania 3
MY - Malesia 3
SA - Arabia Saudita 3
AL - Albania 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
MV - Maldive 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
IE - Irlanda 1
IR - Iran 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
LY - Libia 1
MD - Moldavia 1
MT - Malta 1
NR - Nauru 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UA - Ucraina 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.856
Città #
Ashburn 253
Fairfield 221
Singapore 172
Woodbridge 167
Chandler 154
San Jose 122
Hong Kong 94
Houston 94
Seattle 92
Cambridge 87
Nyköping 83
Wilmington 68
Milan 67
Beijing 63
Ann Arbor 49
New York 44
Bari 40
Los Angeles 29
Ho Chi Minh City 28
Abidjan 24
Lawrence 24
Brooklyn 23
Dallas 23
Munich 23
Roxbury 23
Lauterbourg 22
Brussels 21
Council Bluffs 20
São Paulo 20
Rome 18
Columbus 17
Santa Clara 16
Hanoi 15
Moscow 14
Helsinki 13
London 13
The Dalles 13
Tokyo 13
Des Moines 12
Jakarta 12
Nanjing 12
Paris 11
Boardman 10
San Diego 10
Baghdad 9
Dearborn 9
Turku 9
Falkenstein 8
Montreal 7
Orem 7
Tashkent 7
Vienna 7
Brasília 6
Buffalo 6
Chicago 6
Dong Ket 6
Inglewood 6
Miami 6
Monmouth Junction 6
San Francisco 6
Warsaw 6
Amsterdam 5
Ankara 5
Atlanta 5
Calgary 5
Charlotte 5
Chennai 5
Denver 5
Frankfurt am Main 5
Poplar 5
Porto Alegre 5
Shanghai 5
Toronto 5
Belo Horizonte 4
Chandigarh 4
Detroit 4
Falls Church 4
Figino 4
Johannesburg 4
Marseille 4
Memphis 4
Nanchang 4
Napoli 4
North Bergen 4
Ottawa 4
Phoenix 4
Pune 4
Rio de Janeiro 4
Washington 4
Amman 3
Baku 3
Barranquilla 3
Changsha 3
Curitiba 3
Dhaka 3
Goiânia 3
Haiphong 3
Hortolândia 3
Jiaxing 3
Joinville 3
Totale 2.623
Nome #
New insight into the role of metabolic reprogramming in melanoma cells harboring braf mutations. 223
Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinoma 195
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 192
Drug delivery nanovectors based on SPIONS for targeted therapy of hepatocellular carcinoma 188
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study 188
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors 180
Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives 170
EGFR tyrosine kinases inhibitors in cancer treatment: in vitro and in vivo evidence 166
Anti-EGFR monoclonal antibody in cancer treatment: In vitro and in vivo evidence 165
Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers 155
Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma 149
The coordinated role of CYP450 enzymes and P-gp in determining cancer resistance to chemotherapy 148
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity 146
Synthetic lethality to overcome cancer drug resistance 142
p53 as the main traffic controller of the cell signaling network 133
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models 129
Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer 117
Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination 106
Tomatine displays antitumor potential in in vitro models of metastatic melanoma 103
Long non‐coding rna landscape in prostate cancer molecular subtypes: A feature selection approach 101
BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy 100
The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study 100
Synergistic antiproliferative and antiangiogenic effects of EGFR and mTOR inhibitors 89
Gene Expression Comparison between Alcohol-Exposed Versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis 88
null 86
IRISIN AND METASTATIC MELANOMA: SELECTIVE ANTI-INVASIVENESS ACTIVITY IN BRAF WILD-TYPE CELLS 83
Probing the interaction between cisplatin and the therapeutic monoclonal antibody trastuzumab 81
Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma 79
The role of non-coding RNAs as prognostic factor, predictor of drug response or resistance and pharmacological targets, in the cutaneous squamous cell carcinoma 76
null 71
Cervical cancer benefits from trabectedin combination with the β-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids 47
Totale 3.996
Categoria #
all - tutte 16.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022262 9 31 3 3 21 30 10 15 20 22 29 69
2022/2023393 38 66 26 41 31 51 10 41 64 3 9 13
2023/2024149 16 19 14 11 23 42 2 8 4 3 0 7
2024/2025703 30 13 31 41 40 53 138 80 33 25 71 148
2025/20261.399 218 69 96 140 181 70 107 39 179 134 48 118
2026/202731 31 0 0 0 0 0 0 0 0 0 0 0
Totale 3.996